COVID-19: WHO To Commence Vaccine Trials In Nigeria
The World Health Organization (WHO) has said that Nigeria has expressed interest to be part of the global solidarity trial of the vaccines being developed to tackle COVID-19 pandemic and efforts are underway to start the process in the country.
The Officer in charge, WHO Nigeria and member of the Presidential Task Force (PTF) on COVID-19, Dr. Fiona Braka, said this on Friday in Abuja, at the 24th joint national briefing of the committee. She also said that 89 vaccines are being developed globally, including seven in clinical evaluation and several therapeutics in clinical trials to tackle the COVID-19 pandemic.
She said, “Nigeria has also expressed interest to be part of this solidarity trial and efforts are underway to start the process in Nigeria too.”
According to her, on the subject of vaccines and clinical trials for Covid-19, research and development is an important aspect of the response and researchers around the world are working hard on accelerating the development of vaccines and therapeutics for Covid-19.
She said the WHO has launched various working groups to accelerate various aspects of vaccine development.
Native Reporters
